{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:43:58Z","timestamp":1792791838069,"version":"4.5.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["U10CA037420"],"award-info":[{"award-number":["U10CA037420"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["UG1CA189961"],"award-info":[{"award-number":["UG1CA189961"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["K07CA1688"],"award-info":[{"award-number":["K07CA1688"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["R01CA231014"],"award-info":[{"award-number":["R01CA231014"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cancer-related cognitive decline (CRCD) is an important clinical problem, but limited research exists on assessment of cognitive function in patients with lymphoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The overall objective of this nationwide, prospective, observational study conducted in the National Cancer Institute Community Clinical Oncology Research Program (NCORP) was to assess changes in memory, attention, and executive function in patients with lymphoma from pre- (A1) to postchemotherapy (A2) and to 6 months postchemotherapy (A3). Individuals without cancer served as noncancer controls, paired to patients by age and sex, and assessed at the same time-equivalent points. Longitudinal linear mixed models (LMM) including A1, A2, and A3 and adjusting for age, education, race, sex, cognitive reserve score, baseline anxiety, and depressive symptoms were fit. We assessed changes in patients compared with control participants without cancer and assessed differences in cognitive function in those patients with Hodgkin vs non-Hodgkin disease and by disease subtype. All statistical tests were 2-sided.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with lymphoma (n\u2009=\u2009248) and participants without cancer serving as controls (n\u2009=\u2009212) were recruited from 19 NCORP sites. From pre- to postchemotherapy and from prechemotherapy to 6\u2009months follow-up, patients reported more cognitive problems over time compared with controls (Functional Assessment of Cancer-Therapy-Cognitive Function [FACT-Cog] perceived cognitive impairment effect size (ES) = 0.83 and 0.84 for A1 to A2 and A1 to A3, respectively; P\u2009&amp;lt;\u2009.001; single-item cognitive symptoms ES range = 0.55 to 0.70 inclusive of A1 to A2 and A1 to A3; P\u2009&amp;lt;\u2009.001); the complaints were more pronounced in women with lymphoma compared with men with lymphoma (FACT-Cog Perceived Cognitive Impairment (PCI) score group-by-time-by-sex interaction, P\u2009=\u2009.007). Patients with lymphoma also performed statistically significantly less well on tests of verbal memory and delayed recall, attention and executive function, and telephone-based category fluency.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with lymphoma experience worse patient-reported and objectively assessed cognitive function from prechemotherapy to 6-month follow-up compared with age- and sex-paired controls without cancer assessed at similar time intervals.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jnci\/djab133","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T19:12:08Z","timestamp":1626117128000},"page":"47-59","source":"Crossref","is-referenced-by-count":35,"title":["Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy"],"prefix":"10.1093","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2258-7247","authenticated-orcid":false,"given":"Michelle C","family":"Janelsins","sequence":"first","affiliation":[{"name":"University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2936-5794","authenticated-orcid":false,"given":"Mostafa","family":"Mohamed","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0346-5191","authenticated-orcid":false,"given":"Luke J","family":"Peppone","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0968-8265","authenticated-orcid":false,"given":"Allison","family":"Magnuson","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2071-7351","authenticated-orcid":false,"given":"Elizabeth K","family":"Belcher","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Melnik","sequence":"additional","affiliation":[{"name":"Cancer Research Consortium of West Michigan NCI Community Oncology Research Program, Grand Rapids, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaker","family":"Dakhil","sequence":"additional","affiliation":[{"name":"Wichita NCI Community Oncology Research Program, Wichita, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Geer","sequence":"additional","affiliation":[{"name":"Metro Minnesota Community Oncology Research Program, Saint Louis Park, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4219-4320","authenticated-orcid":false,"given":"Charles","family":"Kamen","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0472-4079","authenticated-orcid":false,"given":"Lori","family":"Minasian","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M","family":"Reagan","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya G","family":"Mohile","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7506-926X","authenticated-orcid":false,"given":"Gary R","family":"Morrow","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7936-2818","authenticated-orcid":false,"given":"Tim A","family":"Ahles","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4869-2221","authenticated-orcid":false,"given":"Charles E","family":"Heckler","sequence":"additional","affiliation":[{"name":"University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"issue":"6","key":"2022011302594444100_djab133-B1","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s00520-020-05860-9","article-title":"Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group","volume":"29","author":"Mayo","year":"2021","journal-title":"Support Care Cancer"},{"issue":"11","key":"2022011302594444100_djab133-B2","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/cncr.20272","article-title":"The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial","volume":"100","author":"Wefel","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"2022011302594444100_djab133-B3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/07347330903183117","article-title":"Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors","volume":"27","author":"Reid-Arndt","year":"2009","journal-title":"J Psychosoc Oncol"},{"issue":"1","key":"2022011302594444100_djab133-B4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jhealeco.2004.07.003","article-title":"Short-term effects of breast cancer on labor market attachment: results from a longitudinal study","volume":"24","author":"Bradley","year":"2005","journal-title":"J Health Econ"},{"issue":"7","key":"2022011302594444100_djab133-B5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1532-5415.2006.00789.x","article-title":"A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy","volume":"54","author":"Hurria","year":"2006","journal-title":"J Am Geriatr Soc"},{"issue":"14","key":"2022011302594444100_djab133-B6","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1200\/JCO.2000.18.14.2695","article-title":"Cognitive function in breast cancer patients receiving adjuvant chemotherapy","volume":"18","author":"Brezden","year":"2000","journal-title":"J Clin Oncol"},{"issue":"29","key":"2022011302594444100_djab133-B7","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1200\/JCO.2009.27.0827","article-title":"Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve","volume":"28","author":"Ahles","journal-title":"J Clin Oncol"},{"issue":"12","key":"2022011302594444100_djab133-B8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/pon.1342","article-title":"Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide","volume":"17","author":"Jansen","year":"2008","journal-title":"Psychooncology"},{"issue":"6","key":"2022011302594444100_djab133-B9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1532-5415.2006.00732.x","article-title":"Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study","volume":"54","author":"Hurria","year":"2006","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"2022011302594444100_djab133-B10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/pon.1379","article-title":"Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment","volume":"18","author":"Collins","year":"2009","journal-title":"Psychooncology"},{"issue":"6","key":"2022011302594444100_djab133-B11","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/sj.bjc.6603029","article-title":"A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer","volume":"94","author":"Jenkins","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"2022011302594444100_djab133-B12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-007-9686-5","article-title":"Cognitive function in breast cancer patients prior to adjuvant treatment","volume":"110","author":"Ahles","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2022011302594444100_djab133-B13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/pon.1210","article-title":"The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study","volume":"17","author":"Stewart","year":"2008","journal-title":"Psychooncology"},{"issue":"1","key":"2022011302594444100_djab133-B14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13803390801992725","article-title":"Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models","volume":"31","author":"Ouimet","year":"2009","journal-title":"J Clin Exp Neuropsychol"},{"issue":"10","key":"2022011302594444100_djab133-B15","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00520-010-0997-4","article-title":"A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients","volume":"19","author":"Jansen","year":"2011","journal-title":"Support Care Cancer"},{"issue":"5","key":"2022011302594444100_djab133-B16","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1200\/JCO.2016.68.5826","article-title":"Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study","volume":"35","author":"Janelsins","year":"2017","journal-title":"J Clin Oncol"},{"issue":"30","key":"2022011302594444100_djab133-B17","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1200\/JCO.2012.43.0116","article-title":"Cancer- and cancer treatment-associated cognitive change: an update on the state of the science","volume":"30","author":"Ahles","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"2022011302594444100_djab133-B18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/pon.4009","article-title":"Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer","volume":"26","author":"Merriman","year":"2017","journal-title":"Psychooncology"},{"issue":"15","key":"2022011302594444100_djab133-B19","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1002\/cncr.29393","article-title":"Patterns of change in cognitive function with anastrozole therapy","volume":"121","author":"Bender","year":"2015","journal-title":"Cancer"},{"issue":"31","key":"2022011302594444100_djab133-B20","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1200\/JCO.2014.56.1662","article-title":"Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study","volume":"32","author":"Ganz","year":"2014","journal-title":"J Clin Oncol"},{"issue":"34","key":"2022011302594444100_djab133-B21","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1200\/JCO.2015.63.0905","article-title":"Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study","volume":"33","author":"Vardy","year":"2015","journal-title":"J Clin Oncol"},{"issue":"6","key":"2022011302594444100_djab133-B22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjh.14211","article-title":"What is known and unknown about chemotherapy-related cognitive impairment in patients with hematological malignancies and areas of needed research","volume":"174","author":"Williams","year":"2016","journal-title":"Br J Hematol Invited Rev"},{"issue":"19","key":"2022011302594444100_djab133-B23","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1200\/JCO.2005.03.343","article-title":"Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy","volume":"23","author":"Ahles","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"2022011302594444100_djab133-B24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/10428194.2014.915546","article-title":"Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine","volume":"56","author":"Zimmer","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2022011302594444100_djab133-B25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/bjh.15448","article-title":"Cognitive impairment in Hodgkin lymphoma survivors","volume":"182","author":"Trachtenberg","year":"2018","journal-title":"Br J Haematol"},{"issue":"12","key":"2022011302594444100_djab133-B26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00210-016-1290-y","article-title":"Early manifestation of mild cognitive impairment in B-cell non-Hodgkin\u2019s lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy","volume":"389","author":"Khan","year":"2016","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"2022011302594444100_djab133-B27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain Behav Immun"},{"issue":"8","key":"2022011302594444100_djab133-B28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression","volume":"29","author":"Gao","year":"2008","journal-title":"Trends Immunol"},{"key":"2022011302594444100_djab133-B29","doi-asserted-by":"crossref","first-page":"45):1-5","DOI":"10.1186\/1471-2318-12-45","article-title":"Examining the influence of sex, education, social class and birth cohort on MMSE tracking over time: a population-based prospective cohort study","volume":"12","author":"Matthews","year":"2012","journal-title":"BMC Geriatr"},{"issue":"29","key":"2022011302594444100_djab133-B30","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1200\/JCO.2009.27.0827","article-title":"Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve","volume":"28","author":"Ahles","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"2022011302594444100_djab133-B31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00520-011-1158-0","article-title":"Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research","volume":"20","author":"Janelsins","year":"2012","journal-title":"Support Care Cancer"},{"issue":"2","key":"2022011302594444100_djab133-B32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jamaoncol.2015.4333","article-title":"Neurotoxic effects of anthracycline- vs nonanthracycline-based chemotherapy on cognition in breast cancer survivors","volume":"2","author":"Kesler","year":"2016","journal-title":"JAMA Oncol"},{"key":"2022011302594444100_djab133-B33","first-page":"36(32):3231-3239","article-title":"Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study","author":"Janelsins","year":"2018","journal-title":"J Clin Oncol"},{"issue":"5","key":"2022011302594444100_djab133-B34","first-page":"266","article-title":"Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers","volume":"5","author":"Robbins","year":"1994","journal-title":"Dementia"},{"issue":"3","key":"2022011302594444100_djab133-B35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1076\/clin.13.3.348.1749","article-title":"Construct and concurrent validity of the Hopkins Verbal Learning Test-revised","volume":"13","author":"Shapiro","year":"1999","journal-title":"Clin Neuropsychol"},{"issue":"1","key":"2022011302594444100_djab133-B36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/arclin\/10.1.21","article-title":"Stability of performance on the Hopkins Verbal Learning Test","volume":"10","author":"Rasmusson","year":"1995","journal-title":"Arch Clin Neuropsychol"},{"key":"2022011302594444100_djab133-B37","volume-title":"Hopkins Verbal Learning Test-Revised Professional Manual","author":"Brandt","year":"2001"},{"issue":"4","key":"2022011302594444100_djab133-B38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/01688639508405143","article-title":"Construct validity in the Trail Making Test: What makes Part B harder?","volume":"17","author":"Gaudino","year":"1995","journal-title":"J Clin Exp Neuropsychol"},{"issue":"1","key":"2022011302594444100_djab133-B39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2466\/pms.1970.30.1.319","article-title":"Effects of age and intelligence on Trail Making Test Performance and validity","volume":"30","author":"Goul","year":"1970","journal-title":"Percept Mot Skills"},{"key":"2022011302594444100_djab133-B40","volume-title":"Comprehensive Trail-Making Test Professional Manual","author":"Reynolds","year":"2002"},{"key":"2022011302594444100_djab133-B41","volume-title":"Controlled Oral Word Association Multilingual Aphasia Examination Professional Manual","author":"Bentonal","year":"1978"},{"key":"2022011302594444100_djab133-B42","volume-title":"Neuropsychological Assessment","author":"Lezak","year":"2004"},{"issue":"6","key":"2022011302594444100_djab133-B43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/ageing\/afl095","article-title":"Telephone assessment of cognitive function in adulthood: the brief test of adult cognition by telephone","volume":"35","author":"Tun","year":"2006","journal-title":"Age Ageing"},{"issue":"6","key":"2022011302594444100_djab133-B44","first-page":"32","article-title":"Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument","volume":"7","author":"Wagner","year":"2009","journal-title":"J Support Oncol"},{"issue":"7","key":"2022011302594444100_djab133-B45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jclinepi.2013.12.011","article-title":"Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients","volume":"67","author":"Cheung","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"2022011302594444100_djab133-B46","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V","article-title":"Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory","volume":"89","author":"Cleeland","year":"2000","journal-title":". Cancer"},{"key":"2022011302594444100_djab133-B47","author":"Wilkinson"},{"key":"2022011302594444100_djab133-B48","first-page":"993","volume-title":"The Use of Psychological Testing for Treatment Planning and Outcomes Assessment","author":"Spielberger","year":"1999","edition":"7th ed."},{"issue":"5","key":"2022011302594444100_djab133-B49","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","article-title":"The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory","volume":"85","author":"Mendoza","year":"1999","journal-title":"Cancer"},{"issue":"3","key":"2022011302594444100_djab133-B50","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2307\/2533558","article-title":"Small sample inference for fixed effects from restricted maximum likelihood","volume":"53","author":"Kenward","year":"1997","journal-title":"Biometrics"},{"key":"2022011302594444100_djab133-B51","doi-asserted-by":"crossref","DOI":"10.1002\/9781119013563","volume-title":"Statistical Analysis with Missing Data","author":"Little","year":"2002"},{"key":"2022011302594444100_djab133-B52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach for multiple testing","author":"Benjamini","year":"1995","journal-title":"J Roy Stat Soc Ser B"},{"issue":"17","key":"2022011302594444100_djab133-B53","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1200\/JCO.19.01866","article-title":"Patient-reported cognitive impairment among women with early breast cancer randomly assigned to endocrine therapy alone versus chemoendocrine therapy: results from TAILORx","volume":"38","author":"Wagner","year":"2020","journal-title":"J Clin Oncol"},{"issue":"7","key":"2022011302594444100_djab133-B54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2020.1728748","article-title":"Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment","volume":"61","author":"Williams","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"18","key":"2022011302594444100_djab133-B55","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.2013.54.2050","article-title":"Cognitive impairment in older patients with breast cancer before systemic therapy: Is there an interaction between cancer and comorbidity?","volume":"32","author":"Mandelblatt","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"2022011302594444100_djab133-B56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00006199-200103000-00004","article-title":"Attention and symptom distress in women with and without breast cancer","volume":"50","author":"Cimprich","year":"2001","journal-title":"Nurs Res"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djab133\/40548789\/djab133.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/114\/1\/47\/42150806\/djab133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/114\/1\/47\/42150806\/djab133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T23:34:18Z","timestamp":1725406458000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/114\/1\/47\/6320069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,7,13]]},"published-print":{"date-parts":[[2022,1,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djab133","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,7,13]]}}}